[1]
Hiremath, S.B. and Lokikere, S.D. 2017. Carvedilol versus beta-1 blockers as anti-hypertensive drugs in type-2 diabetes mellitus and pre-diabetic patients with features of metabolic syndrome: a meta-analysis. International Journal of Basic & Clinical Pharmacology. 5, 4 (Jan. 2017), 1380–1388. DOI:https://doi.org/10.18203/2319-2003.ijbcp20162439.